Journal article Published 2022

New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity

V. Talianova, Z. Kejik, R. Kaplanek, K. Vesela, N. Abramenko, L. Lacina, K. Strnadova, B. Dvorankova, P. Martasek, M. Masarik, Magdalena Houdová Megová, P. Busek, J. Krizova, L. Zdrazilova, H. Hansikova,

Show all 20 authors

E. Vlcak, V. Filimonenko, A. Sedo, K. Smetana Jr., M. Jakubek

Pharmaceutics 14(8), 1712 (2022)

View on PubMed Cite

2022 Year
36015338 PMID

Cite this publication

TALIANOVA, V., Z. KEJIK, R. KAPLANEK, K. VESELA, N. ABRAMENKO, L. LACINA, K. STRNADOVA, B. DVORANKOVA, P. MARTASEK, M. MASARIK, M. HOUDOVÁ MEGOVÁ, P. BUSEK, J. KRIZOVA, L. ZDRAZILOVA, H. HANSIKOVA, E. VLCAK, V. FILIMONENKO, A. SEDO, K. SMETANA JR., M. JAKUBEK: New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity. Pharmaceutics. 2022, 14(8), 1712, ISSN: 1999-4923, PMID: 36015338.

Cite this publication

Details